Brief: Pulmonx Announces Long-Term Follow-Up Data Confirming Significant Benefits Of Zephyr Valve For Patients With Severe Copd/Emphysema
27/07/2021 15:33
July 27 (Reuters) - Pulmonx Corp LUNG.O :
* PULMONX ANNOUNCES LONG-TERM FOLLOW-UP DATA CONFIRMING
SIGNIFICANT BENEFITS OF ZEPHYR VALVE FOR PATIENTS WITH SEVERE
COPD/EMPHYSEMA
Source text for Eikon: ID:nBw3r3Km5a
Further company coverage: LUNG.O
((Reuters.Briefs@thomsonreuters.com;))